In Track Investment Management Inc Crispr Therapeutics Ag Transaction History
In Track Investment Management Inc
- $139 Million
- Q2 2024
A detailed history of In Track Investment Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, In Track Investment Management Inc holds 9,288 shares of CRSP stock, worth $436,443. This represents 0.36% of its overall portfolio holdings.
Number of Shares
9,288
Previous 7,658
21.28%
Holding current value
$436,443
Previous $521,000
3.84%
% of portfolio
0.36%
Previous 0.39%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$370 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$366 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$148 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$148 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$131 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.67B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....